4[1]FAGAN TC, SOWERS J, Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy[ J]. Arch InternMed, 1999, 159: 1033-1034.
5Tzotzas T,Krassas GE,Konstantinidis T,et al.Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment[J].Thyroid,2000,10(9):803-808.
7Shin DJ,Osborme TF.Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2(SREBP-2)[J].J Biol Chem,2003,278(38):34114-34118.
8Pearce EN.Hypothyroidism and dyslipidemia:modern concepts and approaches[J].Curr Cardiol Rep,2004,6(6):451-456.
9Diekman T,Demacker PN,Kastelein JJ,et al.Increased oxidizability of low-density lipop-roteins in hypothyroidism[J].J Clin Endocrinol Metab,1998,83(5):1752-1755.
10Nikolaeva AV,Pimenov LT.Lipid metabolism and functional status of the kidney in hypothyroid patients depending on the phase of disease[J].Ter Arkh,2002,74(10):20-23.
